CareDx to Report First Quarter 2025 Financial Results

Audio By Carbonatix

BRISBANE, Calif.--(BUSINESS WIRE)--Apr 8, 2025--

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the first quarter 2025 after market close on Wednesday, April 30, 2025. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Individuals interested in listening to the conference call may do so by dialing 1-800-445-7795 for domestic callers or 1-785-424-1699 for international callers. Please reference Conference ID: CareDx. To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250408534242/en/

CONTACT: CareDx, Inc.

Investor Relations

Caroline Corner

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH SURGERY TELEMEDICINE/VIRTUAL MEDICINE OTHER HEALTH MANAGED CARE GENERAL HEALTH

SOURCE: CareDx, Inc.

Copyright Business Wire 2025.

PUB: 04/08/2025 07:05 AM/DISC: 04/08/2025 07:07 AM

http://www.businesswire.com/news/home/20250408534242/en